Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07413926 · ClinicalTrials.gov registry record
Mitral Valve Repair With the Chord-X System: A Long Term Evaluation
A clinical trial, sponsored by Artivion.
- Not yet
- Registry status
- 110
- Enrollment target
NCT07413926 is a clinical trial that has not yet begun recruiting, run by Artivion. The registered enrollment target is 110 participants.
The verdict
NCT07413926 has not yet begun recruiting, sponsored by Artivion.
- NOT YET RECRUITING
- Registry status
- 110 participants
- Enrollment target
Study Summary
The goal of this clinical trial is to strengthen the evidence available for the Chord-X System by collecting follow-up data from patients who underwent Chord-X implant and to evaluate the long-term safety and performance data (out to 10 years). Collecting patient health information over time can help to supplement and improve the care of patients in the future. Participants will: Agree to the collection of their past medical history, and the details of their mitral repair surgery with the Chord-X system, including results of the follow-up examinations after implantation Visit the clinic for the routinely scheduled follow-up examination appointments
Interventions
- DEVICE Chord-X system implant
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 110 participants |
| Start Date | 2026-06 |
| Est. Completion | 2034-06 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07413926
The ClinicalTrials.gov registry entry for NCT07413926 describes a study currently listed as not yet recruiting, categorized as an unspecified phase. The registered enrollment target is 110 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Artivion, which has 7 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Chord-X system implant is the first listed.
NCT07413926 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT07413926 about?
NCT07413926 is a clinical study titled "Mitral Valve Repair With the Chord-X System: A Long Term Evaluation". The goal of this clinical trial is to strengthen the evidence available for the Chord-X System by collecting follow-up data from patients who underwent Chord-X implant and to evaluate the long-term safety and performance data (out to 10 years). Collecting patient health information over time can hel...
What is the current status of trial NCT07413926?
This trial is currently not yet recruiting. The enrollment target is 110 participants. The study started on 2026-06. Estimated completion is 2034-06.
What interventions are being tested in trial NCT07413926?
The interventions under investigation include: Chord-X system implant (DEVICE).
Who is sponsoring clinical trial NCT07413926?
This trial is sponsored by Artivion, which has 7 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.